UBE2I and hepatocellular carcinoma: In summary, this study proposed a potential regulatory mechanism involving UBC9, SUMOylated Mettl3, and Snail in HCC progression, suggesting Mettl3 SUMOylation as a promising diagnostic and therapeutic target for liver cancer treatment.